Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.50 |
| ▸ | HTR3B | O95264 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10691837 | 0.83 | TMEM97 (0.70) | ALDH1A1TMEM97HTR2BHTR3EHTR3B | |
| SCHEMBL11563734 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TMEM97HTR2BHTR3EHTR3B | |
| SCHEMBL30987468 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL23967443 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL2653818 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL5520058 | 0.78 | ALDH1A1 (0.57) | ALDH1A1KMT2AMEN1LMNAMAPT | |
| SCHEMBL18935574 | 0.77 | ALDH1A1 (0.62) | ALDH1A1TMEM97HTR2BHTR3EHTR3B | |
| SCHEMBL27267376 | 0.77 | ALDH1A1 (0.48) | ALDH1A1TMEM97HTR2BHTR3EHTR3B | |
| SCHEMBL11813616 | 0.76 | TMEM97 (0.40) | ALDH1A1TMEM97HTR2BHTR3EHTR3B | |
| SCHEMBL28081519 | 0.76 | ALDH1A1 (0.50) | ALDH1A1KMT2AMEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100204431-A1 | METHOD OF MAKING AN AROMATIC POLYETHER COMPOSITION USING PHOSPHAZENIUM SALT PHASE TRANSFER CATALYSTS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-08-12 | — | — | US | disclosed |
| US-7705190-B2 | phosphazenium salt phase transfer catalysts are shown to be especially useful in the preparation of aromatic polyethers such as polyether sulfones; enhanced stability | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-04-27 | — | — | US | disclosed |
| CN-100537032-C | Phosphazenium salt phase transfer catalysts | GEN ELECTRIC (NL) | 2009-09-09 | — | — | CN | disclosed |
| CN-101125300-A | Phosphazenium salt phase transfer catalysts | GEN ELECTRIC (US) | 2008-02-20 | — | — | CN | disclosed |
| US-20070112223-A1 | phosphazenium salt phase transfer catalysts are shown to be especially useful in the preparation of aromatic polyethers such as polyether sulfones; enhanced stability | GENERAL ELECTRIC COMPANY (US) | 2007-05-17 | — | — | US | disclosed |
| US-20060069291-A1 | Phosphazenium salt phase transfer catalysts | GENERAL ELECTRIC COMPANY | 2006-03-30 | — | — | US | disclosed |
| EP-1640067-A2 | Phosphazenium salt phase transfer catalysts | GENERAL ELECTRIC COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112223-A1 | phosphazenium salt phase transfer catalysts are shown to be especially useful in the preparation of aromatic polyethers such as polyether sulfones; enhanced stability | PHOSPHO1, MPST, PGLS | ALDH1A1 4625/4885TMEM97 1185/4885HTR2B 4643/4885 |
| US-20060069291-A1 | Phosphazenium salt phase transfer catalysts | PHOSPHO1, MPST, PAPSS1 | ALDH1A1 4713/4885TMEM97 1304/4885HTR2B 4449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.